Literature DB >> 27320081

Isolation and characterization of a bacteriophage phiEap-2 infecting multidrug resistant Enterobacter aerogenes.

Erna Li1,2, Xiao Wei2, Yanyan Ma3,2, Zhe Yin4, Huan Li2, Weishi Lin2, Xuesong Wang2, Chao Li5, Zhiqiang Shen5, Ruixiang Zhao3, Huiying Yang4, Aimin Jiang1, Wenhui Yang4, Jing Yuan2, Xiangna Zhao2.   

Abstract

Enterobacter aerogenes (Enterobacteriaceae) is an important opportunistic pathogen that causes hospital-acquired pneumonia, bacteremia, and urinary tract infections. Recently, multidrug-resistant E. aerogenes have been a public health problem. To develop an effective antimicrobial agent, bacteriophage phiEap-2 was isolated from sewage and its genome was sequenced because of its ability to lyse the multidrug-resistant clinical E. aerogenes strain 3-SP. Morphological observations suggested that the phage belongs to the Siphoviridae family. Comparative genome analysis revealed that phage phiEap-2 is related to the Salmonella phage FSL SP-031 (KC139518). All of the structural gene products (except capsid protein) encoded by phiEap-2 had orthologous gene products in FSL SP-031 and Serratia phage Eta (KC460990). Here, we report the complete genome sequence of phiEap-2 and major findings from the genomic analysis. Knowledge of this phage might be helpful for developing therapeutic strategies against E. aerogenes.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27320081      PMCID: PMC4913238          DOI: 10.1038/srep28338

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


Enterobacter aerogenes is a gram-negative bacterium of the Enterobacteriaceae family1. This bacterium is widely found in the human gastrointestinal tract and environment2. E. aerogenes has been reported to be an important opportunistic pathogen for humans3, and it is resistant to multiple antibiotics that are normally used to treat infections caused by Enterobacter4. It causes hospital-acquired infections such as pneumonia, bacteremia, urinary tract infection, surgical site infection, and meningitis2. Phages by their very nature would seem to be good candidates for antibacterial therapy5. Although the use of phages for therapeutic purposes has raised concerns over the potential for immunogenicity, restriction/modification, rapid toxin release by lytic action, development of bacteria resistance and so on5678, phage therapy was still actively pursued. For example, a Siphoviridae phage 1535 against K. pneumoniae has been reported to have great potential for treating pneumonia and other infections caused by K. pneumoniae9, and the application of the Yersinia phage PY100 for the control of Y. enterocolitica at the post-harvest level seems to be promising10. To date, there are only two reported E. aerogenes phages, F20 (JN672684)4 which is a member of the Siphoviridae family of T1-like viruses, and an unclassified phage UZ111. To expand the repertoire of phages available for targeting clinically relevant E. aerogenes, a novel phage (phiEap-2) against E. aerogenes was isolated from hospital sewage, and the biology and genomics of the phage were characterized. This phage has specific lytic activity against a carbapenem-nonsusceptible E. aerogenes strain, 3-SP, which contains an NDM-1 carbapenemase-producing plasmid designated as p3SP-NDM and is resistant to multiple β-lactam antibiotics including imipenem and meropenem2. The phage is a member of the Siphoviridae family; the morphology, one-step growth curve, stability studies and complete genome sequence of the phage were determined.

Results and Discussion

Morphology

Phage phiEap-2 produced large, clear, round plaques of 1–2 mm in diameter on a lawn of E. aerogenes 3-SP (Fig. 1a). The phage was purified and examined by TEM after negative staining (Fig. 1b). The phage had a capsid that was 55 nm in diameter and a non-contractile tail that was about 117 nm long and 10 nm in diameter; these morphological features indicate that this virus belongs to the Siphoviridae family. Host range tests suggested that phiEap-2 was specific for E. aerogenes (Table 1).
Figure 1

Isolated enterobacteria phage phiEap-2.

(a) Plaques of phage phiEap-2 on E. aerogenes 3-SP. (b) Transmission electron micrograph (TEM) of phage phiEap-2 at × 150 000. The bar indicates 100 nm. (c) One-step growth curve of phiEap-2. Phages were grown in an exponential phase culture of E. aerogenes. (d) Stability of phage phiEap-2 at different temperatures. (e) Stability of phage phiEap-2 at different pH.

Table 1

Host range infection of the phage phiEap-2 and efficiency of plating.

SpeciesIDInfectionEfficiency of plating (EOP)
E. aerogenes3-SP+1.00
E. aerogenes201316724+1.12
E. aerogenes2015-301+0.84
E. aerogenes132080
E. aerogenesA298640
E. aerogenesA361790
E. aerogenesAH100
E. aerogenesAH12+0.97
E. aerogenesAH13+0.85
E. aerogenesAH14+0.60
E. aerogenesAH15+0.20
E. aerogenesAH17+0.51
E. aerogenesAH18+1.03
E. aerogenesAH20
E. aerogenesAH20+0.18
E. aerogenesAH21+1.01
E. aerogenesAH22+0.59
E. aerogenesAH240
E. aerogenesAH25+0.03
E. aerogenesAH28+1.12
E. aerogenesAH29+0.63
E. aerogenesAH3+0.23
E. aerogenesAH30+0.29
E. aerogenesAH32+0.80
E. aerogenesAH330
E. aerogenesAH34+0.61
E. aerogenesAH36+0.75
E. cloacaeT52820
E. cloacaeTI30
E. sakazakii454010
E. sakazakii454020
Serratia marcescenswk20500
S. marcescens2013157320
S. marcescenswj-10
S. marcescenswj-20
S. marcescenswj-30
Escherichia coliATCC 259220
Klebsiella pneumoniaeATCC BAA-17060
Achromobacter xylosoxidansA227320
Leclercia adcarboxglataP101640
Raoultella ornithinolyticaYNKP0010
Stenotrophomonas maltophilia96650
Citrobacter freundiiP101590
Vibrio parahaemolyticusJ54210
Pseudomonas aeruginosaPA010
Acinetobacter baumanniiN10
Shigella sonnei#10830

−absent; +present.

Life cycle parameters

Multiplication parameters of phage phiEap-2 were determined using one-step growth curve conditions (Fig. 1c). The latent period, defined as the time interval between the adsorption and the beginning of the first burst, was about 25 min. A burst time of 60 min and average burst size of 100 plaque-forming units (pfu)/cell, which was calculated as the ratio of the final count of liberated phage particles to the initial count of infected bacterial cells during the latent period, were observed. The thermal stability of phage phiEap-2 was determined at different temperatures from 4 to 80 °C (Fig. 1d). No significant loss in the phage titer was observed from 4 to 37 °C. Phage phiEap-2 had a titer reduction at 50 °C, and the titers dramatically decreased at 60 °C. Stability of phage phiEap-2 with different pH were also conducted (Fig. 1e). The phage was stable over a broad range of pH from 6 to 11. A significant reduction in phage titre was observed when it was extremely acidic (pH 3) or basic (pH 14). It was noticed that still nearly half of the phages existed at pH 4 or pH 13. The results suggested that the phage appears to tolerate better basic than acidic conditions.

General features of the phiEap-2 genome

The genome of phage phiEap-2 is 40,491 bp in length with a 51.95% GC content. When the original sequencing was completed, the assembly of the random library of sequences yielded a closed, circular genome. However, based on the genome sequence analysis and the length of the fragments generated by digestion with AhdI (Fig. 2a) and SacI (Fig. 2b), the genome is linear rather than circular. Sixty-two open reading frames (ORFs) were predicted in the phage genome. Twenty-three ORFs were functionally annotated, and thirty-nine ORFs were annotated as hypothetical proteins. The orientation of genome annotation was chosen so that most genes (71%) were on the plus strand. The capsid and tail genes were identified, as well as representatives of the DNA replication, packaging, and lysis proteins. Comparative genome analysis of phiEap-2 with existing phages supports the hypothesis that phiEap-2 has no similarity to the previously published E. aerogenes phage F204, but it is related to the previously sequenced Salmonella phage FSL SP-031 (KC139518)12 (Fig. 3). Both of phiEap-2 and FSL SP-031 belong to the Siphoviridae family of viruses. This family is characterized by having a double-stranded DNA genome, an isometric head, and a long, non-contractile tail. FSL SP-031 encoded 59 predicted proteins despite a genome of 42, 215 bp, which was larger than that of phiEap-2. For comparison, the GC content of FSL SP-031 is 51.3%. PhiEap-2 and FSL SP-031 shared thirty-five orthologous genes; the amino acid identities for these genes are shown in Table 2. The phiEap-2 phage has a similar gene arrangement that was observed in other Siphoviridae phages13: genes for head and tail assembly were arranged together with the head genes 5′ to the tail genes. phiEap-2 genes were categorized into three functional groups according to the homology search-based annotation of functional genes (Fig. 4). ORF information, such as the position of genes, protein length, directions of transcription, size, function, and homology between phiEap-2 genes and other phage-related genes, is shown in Table 2.
Figure 2

Restriction fragment length polymorphism analysis of phiEap-2 DNA.

Genomic DNA from phage phiEap-2 was digested with the enzymes indicated (AhdI and SacI) and run on an agarose gel (0.7%). The length of fragments generated by digestion of the linear genome or the circular genome was showed on the right side of the electrophoresis map.

Figure 3

Phylogenetic tree based on large terminase subunits of selected bacteriophages.

The large terminase subunits were compared using the ClustalW program, and the phylogenetic tree was generated using the neighbour-joining method and 1000 bootstrap replicates. FSL SP-031, GenBank accession no. NC_021775; phiEap-2, GenBank accession no. KT287080; Eta, GenBank accession no. KC460990; FSL SP-101, GenBank accession no. KC139511; K1-dep(1), GenBank accession no. GU196278; SS3e, GenBank accession no. NC_006940; T1, GenBank accession no. AY216660.

Table 2

Phage phiEap-2 gene annotations.

ORFsStrandNucleotide positionLength (aa)aConserved Protein Domain FamilyBest match (%)Vs FSL SP-031Vs EtaFunction
ORF1+409–58258     
ORF2+582–983133 FSL SP-031 orf18 (54%)orf18 (54%)  
ORF3+976–1494172pfam13392; pfam00847; PHA00280SETP7 orf42 (49%)  HNH endonuclease
ORF4+1491–168865 FSL SP-031 orf19 (89%)orf19 (89%)  
ORF5+1770–2096108pfam11753FSL SP-031 orf20 (82%)orf20 (82%)  
ORF6+2500–278193 SETP7 orf57 (53%)orf22 (53%)  
ORF7+2783–306794 SETP7 orf58 (57%)orf23 (45%) Class I holin
ORF8+3048–3533161cd00737; COG3772; pfam00959FSL SP-031 orf24 (80%)orf24 (80%) Lysozyme
ORF9+3772–395762     
ORF10+3954–409747 FSL SP-031 orf25 (93%)orf25 (93%)  
ORF11+4275–444556pfam10930FSL SP-031 orf26 (87%)orf26 (87%)  
ORF12+4585–482178 FSL SP-031 orf27 (49%)orf27 (49%)  
ORF13+4818–497352 FSL SP-031 orf28 (50%)orf28 (50%)  
ORF14+4960–522086 pYD38-A orf74 (74%)   
ORF15+5223–544473pfam06322FSL SP-031 orf29 (72%)orf29 (72%)  
ORF16+5441–560856     
ORF17+5738–6241167 FSL SP-031 orf31 (60%)orf31 (60%)  
ORF18+6216–7487423TIGR01547; pfam03237FSL SP-031 orf32 (89%)orf32 (89%)orf40 (57%)Terminase large subunit
ORF19+7500–8987495pfam13264K1-dep(1) orf2 (80%)orf33 (77%)orf42 (65%)Structural protein
ORF209014–921768     
ORF21+9302–10345347TIGR01641; pfam04233; COG2369FSL SP-031 orf34 (91%)orf34 (91%)orf43 (66%)Head morphogenesis protein
ORF22+10345–10794149pfam07679FSL SP-031 orf35 (67%)orf35 (67%)orf44 (55%)Tail protein
ORF23+10794–11363189 FSL SP-031 orf35 (35%)orf35 (35%)orf44 (35%) 
ORF24+11367–1150144 BA3 orf20 (66%)   
ORF2511567–1177971 Acj61 p098 (39%)   
ORF26+12153–12542129 FSL SP-031 orf37 (61%)orf37 (61%)  
ORF27+12736–13386216 Eta orf50 (64%)orf40 (54%)orf50 (64%)Scaffold protein
ORF28+13393–14361322 K1-dep(1) orf8 (93%)  Major capsid protein
ORF29+14422–1460761 K1-dep(1) orf 9 (56%)   
ORF30+14611–15117168PRK00007FSL SP-031 orf45 (75%)orf45 (75%)orf54 (70%)Head-tail joining protein
ORF31+15120–15743207 FSL SP-031 orf46 (73%)orf46 (73%)orf55 (72%)Neck protein
ORF32+15740–16099119 FSL SP-031 orf47 (82%)orf47 (82%)orf56 (77%)Tail protein
ORF33+16096–16494132pfam04883FSL SP-031 orf48 (58%)orf48 (58%)orf57 (51%)Tail protein
ORF34+16494–16910138pfam13554FSL SP-031 orf49 (90%)orf49 (90%)orf58 (81%)Tail protein
ORF35+16913–18085390 FSL SP-031 orf50 (86%)orf50 (86%)orf59 (77%)Tail protein
ORF3618108–18440111 FSL SP-031 orf51 (41%)orf51 (41%)  
ORF37+18602–19018138 FSL SP-031 orf52 (82%)orf52 (82%)orf61 (57%) 
ORF38+19108–1938090 FSL SP-031 orf53 (81%)orf53 (81%)orf62 (53%) 
ORF39+19373–21607744pfam06791; PTZ00121FSL SP-031 orf54 (65%)orf54 (65%)orf63 (53%)Tail tape measure protein
ORF40+21610–22104164 Eta orf64 (75%)orf55 (64%)orf64 (75%) 
ORF41+22101–22613170pfam08875Eta orf66 (78%)orf56 (69%)orf66 (78%) 
ORF42+22673–22975100 Eta orf67 (64%)orf57 (58%)orf67 (64%) 
ORF43+23041–25557838COG4733FSL SP-031 orf58 (60%)orf58 (60%)orf68 (60%)Tail fiber protein
ORF44+25570–27558662pfam12708; pfam13229; TIGR04247Eta orf69 (37%)orf59 (24%)orf69 (37%)Tailspike protein
ORF45+27555–2770750     
ORF4627736–2799386pfam13600; cd14812FSL SP-101 orf1 (72%)orf1 (68%)  
ORF4727996–29432478cd00046; pfam00271; pfam00176; smart00487; COG0553FSL SP-031 orf2 (96%)orf2 (96%) Helicase
ORF4829429–2957248     
ORF4929572–2974558     
ORF5029736–30080114PHA00527Marshall orf108 (47%)   
ORF5130077–30469130pfam08774FSL SP-031 orf3 (65%)orf3 (65%) Restriction endonuclease
ORF5230552–31031159pfam13392; pfam00847; PHA00280    
ORF5331021–33234737cd08642; smart00482; pfam00476; pfam01612; PRK14975; TIGR00593; COG0749FSL SP-031 orf5 (74%)orf5 (74%) DNA polymerase I
ORF5433293–33973226pfam10991FSL SP-031 orf7 (85%)orf7 (85%)  
ORF5534058–35452464pfam10926FSL SP-031 orf9 (72%)orf9 (72%)  
ORF5635452–3568878 FSL SP-031 orf11 (58%)orf11 (58%)  
ORF5735685–3590674     
ORF5835955–3611353     
ORF5936117–36608163PRK13108; TIGR00457FSL SP-031 orf14 (42%)orf14 (42%)  
ORF6036611–37099162pfam13392; pfam00847; PHA00280SETP7 orf42 (67%)  HNH endonuclease
ORF61+37244–3746573cd00093; pfam13443; smart00530; COG3655; PRK09706; COG1396FSL SP-031 orf15 (39%)orf15 (39%)  
ORF62+37594–39897767pfam13481; cd01125FSL SP-031 orf16 (75%)orf16 (75%) Replicative helicase/primease

aamino acids.

Figure 4

Genomic structure of phiEap-2.

The genome map was performed using the CLC Main Workbench, version 6.1.1 (CLC bio, Aarhus, Denmark). Arrows represent predicted ORFs, the direction of the arrow represents the direction of transcription. Different colors denote different functional groups of bacteriophage genes.

DNA metabolism

At least six genes in the phiEap-2 genome that play a role in nucleotide metabolism were identified, including a helicase, a replicative helicase-primase, a restriction endonuclease, a DNA polymerase, and two alleles of HNH endonuclease. gp47 encodes a helicase consisting of an SNF2 family N-terminal domain (pfam00176) and a helicase-conserved C-terminal domain (pfam00271). A BLASTP search of the helicase revealed significant identity with the FSL SP-031 orf2 (96%). gp62, which encodes a replicative helicase-primase containing an AAA_25 (pfam13481) domain and a hexameric replicative helicase RepA region, showed 75% identity with FSL SP-031 orf16. The restrictive endonuclease encoded by gp51 of phiEap-2 showed homology to FSL SP-031 orf3 (65%) and contained a VRR-NUC domain (pfam08774). gp53, which encodes a DNA polymerase I containing a 3′-5′ exonuclease domain (pfam01612) and a DNA polymerase family A domain (pfam00476), showed similarity to FSL SP-031 orf5 (74%). Proteins containing an HNH motif bind to nucleic acids and possess endonuclease activity14. The two HNH endonucleases encoded by gp60 and gp3 were homologous except for some amino acid changes; both of the proteins consist of an AP2 domain (pfam00847) and an HNH endonuclease domain (pfam13392), and they shared 67% and 49% identity with Salmonella phage SETP7 (NC_022754) gp42, respectively. The HNH endonucleases are unique to phiEap-2 compared with FSL SP-031.

Cell wall lysis-related genes

PhiEap-2 has a holin-encoding gene (gp7) immediately upstream of the lysozyme gene (gp8), suggesting that it may use a holin-dependent lytic mechanism. The lysis genes are located to the left of the terminase gene. As in many other double-stranded DNA phages, gp7, which encodes a predicted holin composed of 94 amino acids, and gp8, which encodes a lysozyme with 80% homology to the FSL SP-031 orf24, seemed to be involved in the holin-endolysin system.

Structural proteins

The arrangement of genes encoding phiEap-2 structure assembly proteins followed the conserved synteny and gene orders of Siphovirus13. Entire structural gene products encoded by phiEap-2, except for capsid protein, had orthologous gene products in FSL SP-031 and Eta (Table 2). The observation revealed a significant evolutionary relationship between FSL SP-031 and Eta. BLASTP analysis of gp18 of phiEap-2 showed significant homology to the C-terminal sequence of the Eta terminase large subunit. Different from Eta, whose terminase small subunit was located immediately upstream of the terminase large subunit, the phiEap-2 phage has only one terminase subunit. It is necessary to point out that gp28, especially the region that encodes the major capsid protein of phiEap-2, revealed extensive conservation with Escherichia phage K1-dep(1) and had no sequence similarity with FSL SP-031 or Eta, although coat proteins of FSL SP-031 and Eta were located in the same position of the genome. Five ORFs (gp22 and gp32–35) were annotated as tail proteins, and they had amino acid identities with FSL SP-031 orthologous genes that ranged from 58% to 90%. Tail fibers and tailspikes are appendages in the phage tail that facilitate the initial binding of the phage to the bacterial host and have a role in host specificity12. The tail fiber protein encoded by gp43 shares 60% amino acid identity with FSL SP-031 orf58. The tailspike protein encoded by gp44 has a mosaic nature: the N terminus displayed similarity (59%) to FSL SP-031 orf59, and the C-terminus more closely resembles a hypothetical protein of E. aerogenes. This observation is consistent with previous reports that these genes often show diversity due to recombination12 and also may suggest that these genes are linked to the evolution of host specificity12. phiEap-2 gp39, which encodes a tape measure protein (TMP) and is the largest gene in the genome, contains a TMP_2 domain (pfam06791) in the N-terminal end. TMP is important for the assembly of phage tails, is involved in tail-length determination, and corresponds to the length of the phage tail1516. Comparisons of the phiEap-2 and FSL SP-031 proteins revealed 65% identity, and the N and C termini were highly similar.

Concluding remarks

The emergence of multiple antibiotic resistant E. aerogenes strains has limited the use of antibiotics to control this pathogen. The phiEap-2 genome does not encode any phage lysogeny factors, toxins, antibiotic resistance genes or pathogen-related genes, indicating that phiEap-2 may be considered a virulent phage with no side effects. Stability is the primary requirement when considering phage for commercial use4. Here, we isolated a phage from sewage, reported its sequence analysis, and presented data relating to its initial characterization. TEM showed that the phage belonged to the Siphoviridae family; these phage possess isometric heads and long, non-contractile tails. The genome of the phage was found to be double-stranded DNA and showed sequence homology to Salmonella phage FSL SP-031. The structural gene module showed a degree of sequence conservation with FSL SP-031 and Serratia phage Eta. The evolution of phage is thought to involve the exchange of functional modules via the loss or acquisition of genetic material by recombination between phage and also between phage and their hosts. The evolutionary advantage of this genetic recombination is thought to assist phage in their permanent adaptation to changing environmental conditions or in their quest to infect new hosts17. Although there is significant diversity among phages18, the structural gene module was found at an equivalent location in the genomes of the three members of the Siphoviridae (phiEap-2, FSL SP-031 and Eta), indicating an evolutionary connection between these phage. Characterization of phage phiEap-2 will assist in its exploitation as a therapeutic candidate against E. aerogenes and as a biocontrol agent to prevent contamination by E. aerogenes. However, considering the development of bacterial resistance to phage and the fact that relatively few candidate phage that lyse E. aerogenes have been properly characterized, there is demand for the isolation of novel E. aerogenes phage to expand the repertoire of phage available for targeting clinically significant E. aerogenes. Furthermore, an increased repertoire of available phage may allow for the development of multi-phage cocktails that may be broadly effective against a wide range of bacterial targets. In our future work, this possibility will be explored. In this study, the phenotypic features and genetic properties of the phage were examined, providing the basis for future therapeutic work. The sequenced phage might also be used in investigations of phage–bacterium interactions.

Methods

Phage isolation

E. aerogenes strains were grown in Luria–Bertani (LB) broth medium at 37 °C. Multidrug-resistant E. aerogenes strain 3-SP was used as a host strain for phage isolation from Bejing hospital sewage. The sewage samples were centrifuged at 12,000 × g for 10 min to remove the solid impurities. The supernatants were filtered through a 0.22-μm pore-size membrane filter to remove bacterial debris. Filtrate (300 μL) was added to 5 ml LB broth medium and mixed with 200 μL E. aerogenes culture (optical density at 600 nm, OD600 = 0.6) to enrich the phage at 37 °C for 8 h. Then, the culture was centrifuged at 12,000 × g for 10 min, and the supernatant was filtered with a 0.22-μm pore-size membrane filter to remove the residual bacterial cells. Filtrate diluted into medium (100 μL) was mixed with 300 μL E. aerogenes in LB culture (OD600 = 0.6) and 3 ml molten top soft nutrient agar (0.7% agar), which was then overlaid on solidified base nutrient agar (1.5% agar)19. Following incubation for 8 h at 37 °C, clear phage plaques were picked from the plate. The phage titer was determined using the double-layered method.

Purification of the phage

To prepare phiEap-2 for transmission electron microscopy (TEM) studies, cell debris from 400 ml E. aerogenes strain 3-SP infected with phiEap-2 was pelleted by low-speed centrifugation (8,500 × g, 20 min, 4 °C). Phage particles were precipitated with 1 M NaCl and 10% polyethylene glycol (PEG) 8000 at 4 °C with stirring for 60 min. The precipitated phage particles were harvested by low-speed centrifugation (8,500 × g, 20 min, 4 °C). Phage particles were resuspended in TM buffer (50 mM Tris-HCl [pH 7.8], 10 mM MgSO4) and extracted with an equal volume of chloroform. After low-speed centrifugation (3,000 × g, 15 min, 4 °C), the aqueous phase was sedimented at about 25,000 × g for 60 min20.

Electron microscopy

Phage particles were negatively stained with 2% (wt/vol) phosphotungstic acid, pH 7. Stained particles were observed in a Philips EM 300 electron microscope operated at 80 kV. Dimensions were measured on photographic prints at a final magnification of 150,000×21.

One-step growth curve

A mid-exponential-phase culture (10 ml) of E. aerogenes strain 3-SP (OD600 = 0.4 to 0.6) was harvested by centrifugation and resuspended in 0.25 volume of fresh LB (ca. 109 colony-forming units/ml). 106–107 pfu/ml phage was added at a multiplicity of infection of 0.1 and allowed to adsorb for 5 min at room temperature. The mixture was then centrifuged at 10,000 rpm for 10 min at room temperature, pelleted cells were resuspended in 10 ml LB, and incubation was continued at 37 °C. Samples were taken at 10-min intervals for 80 min. The samples were immediately diluted and plated for phage titration22. Burst size is calculated as the ratio of the final count of liberated phage particles to the initial count of infected bacterial cells during the latent period. Measurement of phage’s latent-period duration was accomplished by detecting the delay between phage adsorption of a bacterium and the liberation of phage virions232425.

Stability

A temperature-controlled incubator or water bath was used to determine the stabilities at different temperatures or pH. Briefly, a 1.5-ml tube containing equal volumes of phage (2.5 × 108 pfu/ml) were incubated at a specified temperature or pH. After treatment, the tube was cooled slowly and placed in an ice water bath; samples were assayed to determine surviving phages. The results were expressed as a percentage of the initial viral counts. Each assay was performed as three repetitions and the values represented are the means.

Host range determination

The lytic activity of phiEap-2 was tested against 14 species as determined by standard spot tests26. The strains to be tested were grown overnight in LB. Briefly, 10 μL purified phage suspension containing approximately 108 pfu/ml were spotted in the middle of a lawn of bacteria and left to dry before overnight incubation. Bacterial sensitivity to a bacteriophage was established by bacterial lysis at the spot where the phage was deposited. Each strain was tested three times at 37 °C. Efficiency of plating (EOP), the ratio of pfu/ml obtained with an assay host to the pfu/ml obtained with the isolation host, was calculated using the double layer plaque method. Assay host refers to the tested E. aerogenes clinical isolates, and isolation host refers to the E. aerogenes isolate 3-SP with which we initially isolated the phage.

Preparation of phage DNA

The precipitated phage were resuspended in SM buffer27 and purified by Caesium chloride (CsCl) gradient ultracentrifugation based on a method previously described28. The gradients were prepared in Beckman SW32.1 tubes by subsequently underlaying 1.5 ml of each 1.33, 1.45, 1.6 and 1.7 g/cm3 CsCl solution. Phages were gently added on top of the 1.33 g/cm3 CsCl. The tubes were centrifuged at 140,000 g for 3 h at 4 °C. The opalescent phage band was collected using a glass pasteur pipette and dialysed (1000 kDa MWCO), twice for 2 h and once overnight, against 250 volumes (500 ml) of SM buffer to remove CsCl. Phages were concentrated and the titre was determined. Purified phage titres were 1 × 1011 pfu/ml and stored in the dark at 4 °C 28. DNA of high titer suspensions (1010 pfu/ml) of filtered phage lysate was extracted with the phenol-chloroform (24:1, vol/vol) method and precipitated with ethanol. The samples were analyzed on 0.7 to 1.0% agarose gels.

Genome sequencing and computational analysis

The purified phage phiEap-2 genomic DNA was sequenced using an Illumina HiSeq 2500 sequencer. The preparation of the library was done using a KAPA Hyper Prep Kit Illumina platforms following the manufacturer’s instructions. The assembly used 7,907,550 reads, or 988.4 MB, of raw data to give a 24410 × coverage of the genome. The reads were assembled using SSAKE (v3.8) assembly software. The final assembled sequence was searched against the current protein and nucleotide databases (http://www.ncbi.nlm.nih.gov/) using the basic local alignment search tool (BLAST)29. Protein BLAST (BLASTP) (http://www.ncbi.nlm.nih.gov/BLAST/) was used to identify putative homologies and proteins sharing similarities with predicted phage proteins. The CLC Main Workbench, version 6.1.1 (CLC bio, Aarhus, Denmark), was used for genome annotation. Simulation of the restriction enzyme mapping of the phiEap-2 genome sequence was carried out using the software package DNAStar. The phiEap-2 DNA was digested by selected restriction endonucleases (AhdI and SacI, purchased from New England Biolabs, Ipswich, MA, USA). For a reaction system of 20 μL, 10 units of the restriction endonuclease and 200 ng of phiEap-2 DNA were used. The mixture was incubated at 37 °C for 120 min and then used to perform agarose gel electrophoresis. Agarose gel electrophoresis was subsequently performed to separate the restriction fragments. Phylogenetic analysis with the published genome sequences of related phages was performed using ClustalW. Multiple sequence alignment was carried out using Mauve software.

Additional Information

Accession code: The annotated genome sequence for the phage phiEap-2 was deposited in the NCBI nucleotide database under the accession number KT287080. How to cite this article: Li, E. et al. Isolation and characterization of a bacteriophage phiEap-2 infecting multidrug resistant Enterobacter aerogenes. Sci. Rep. 6, 28338; doi: 10.1038/srep28338 (2016).
  29 in total

1.  Conserved translational frameshift in dsDNA bacteriophage tail assembly genes.

Authors:  Jun Xu; Roger W Hendrix; Robert L Duda
Journal:  Mol Cell       Date:  2004-10-08       Impact factor: 17.970

2.  Preparation of a phage DNA fragment library for whole genome shotgun sequencing.

Authors:  Elizabeth J Summer
Journal:  Methods Mol Biol       Date:  2009

Review 3.  Bacteriophage therapy.

Authors:  W C Summers
Journal:  Annu Rev Microbiol       Date:  2001       Impact factor: 15.500

4.  Bacteriophage phiYeO3-12, specific for Yersinia enterocolitica serotype O:3, is related to coliphages T3 and T7.

Authors:  M Pajunen; S Kiljunen; M Skurnik
Journal:  J Bacteriol       Date:  2000-09       Impact factor: 3.490

5.  Phage host range and efficiency of plating.

Authors:  Elizabeth Kutter
Journal:  Methods Mol Biol       Date:  2009

6.  Control of Campylobacter spp. and Yersinia enterocolitica by virulent bacteriophages.

Authors:  Stefanie Orquera; Greta Gölz; Stefan Hertwig; Jens Hammerl; Doreen Sparborth; Alma Joldic; Thomas Alter
Journal:  J Mol Genet Med       Date:  2012-04-24

7.  Lysis-deficient phages as novel therapeutic agents for controlling bacterial infection.

Authors:  Vivek Daniel Paul; Sudarson Sundarrajan; Sanjeev Saravanan Rajagopalan; Sukumar Hariharan; Nanjundappa Kempashanaiah; Sriram Padmanabhan; Bharathi Sriram; Janakiraman Ramachandran
Journal:  BMC Microbiol       Date:  2011-08-31       Impact factor: 3.605

8.  Genome, Proteome and Structure of a T7-Like Bacteriophage of the Kiwifruit Canker Phytopathogen Pseudomonas syringae pv. actinidiae.

Authors:  Rebekah A Frampton; Elena Lopez Acedo; Vivienne L Young; Danni Chen; Brian Tong; Corinda Taylor; Richard A Easingwood; Andrew R Pitman; Torsten Kleffmann; Mihnea Bostina; Peter C Fineran
Journal:  Viruses       Date:  2015-06-24       Impact factor: 5.048

9.  Draft Genome Sequence of Enterobacter aerogenes, a DDE-Degrading and Plant Growth-Promoting Strain Isolated from Cucurbita pepo.

Authors:  Nele Eevers; Jonathan D Van Hamme; Eric M Bottos; Nele Weyens; Jaco Vangronsveld
Journal:  Genome Announc       Date:  2015-04-16

10.  Genomic characterization provides new insight into Salmonella phage diversity.

Authors:  Andrea I Moreno Switt; Renato H Orsi; Henk C den Bakker; Kitiya Vongkamjan; Craig Altier; Martin Wiedmann
Journal:  BMC Genomics       Date:  2013-07-17       Impact factor: 3.969

View more
  11 in total

1.  Complete genomic sequence of bacteriophage P23: a novel Vibrio phage isolated from the Yellow Sea, China.

Authors:  Yundan Liu; Lei Zhao; Min Wang; Qi Wang; Xinran Zhang; Yuye Han; Meiwen Wang; Tong Jiang; Hongbing Shao; Yong Jiang; Andrew McMinn
Journal:  Virus Genes       Date:  2019-08-16       Impact factor: 2.332

2.  Isolation and Complete Genome Sequence of a Novel Pseudoalteromonas Phage PH357 from the Yangtze River Estuary.

Authors:  Zheng Gong; Min Wang; Qingwei Yang; Zhongshi Li; Jun Xia; Yu Gao; Yong Jiang; Xue Meng; Zhaoyang Liu; Ding Yang; Fangfei Zhang; Hongbing Shao; Duobing Wang
Journal:  Curr Microbiol       Date:  2017-04-20       Impact factor: 2.188

3.  A case report of Klebsiella aerogenes-caused lumbar spine infection identified by metagenome next-generation sequencing.

Authors:  Huajie Gu; Qingqing Cai; Xiaoyong Dai; Huanhuan Wang; Wenying Xu; Xuejie Cao; Youwen Ye
Journal:  BMC Infect Dis       Date:  2022-07-15       Impact factor: 3.667

4.  Isolation and Characterization of Lytic Bacteriophages Targeting Diverse Enterobacter spp. Clinical Isolates.

Authors:  Amanda G Finney; Jalyne M Perry; Daniel R Evans; Kevin J Westbrook; Christi L McElheny; Alina Iovleva; Yohei Doi; Ryan K Shields; Daria Van Tyne
Journal:  Phage (New Rochelle)       Date:  2022-03-18

5.  Characterization of a newly isolated phage infecting pathogenic Escherichia coli and analysis of its mosaic structural genes.

Authors:  Qin Peng; Yihui Yuan
Journal:  Sci Rep       Date:  2018-05-24       Impact factor: 4.379

6.  The therapeutic potential of bacteriophages targeting gram-negative bacteria using Galleria mellonella infection model.

Authors:  Prasanth Manohar; Ramesh Nachimuthu; Bruno S Lopes
Journal:  BMC Microbiol       Date:  2018-08-31       Impact factor: 3.605

Review 7.  Phages for Phage Therapy: Isolation, Characterization, and Host Range Breadth.

Authors:  Paul Hyman
Journal:  Pharmaceuticals (Basel)       Date:  2019-03-11

8.  Genome analysis of a wild rumen bacterium Enterobacter aerogenes LU2 - a novel bio-based succinic acid producer.

Authors:  Hubert Szczerba; Elwira Komoń-Janczara; Mariusz Krawczyk; Karolina Dudziak; Anna Nowak; Adam Kuzdraliński; Adam Waśko; Zdzisław Targoński
Journal:  Sci Rep       Date:  2020-02-06       Impact factor: 4.379

9.  vB-Ea-5: a lytic bacteriophage against multi-drug-resistant Enterobacter aerogenes.

Authors:  Fatemeh Habibinava; Mohammad Reza Zolfaghari; Mohsen Zargar; Salehe Sabouri Shahrbabak; Mohammad Soleimani
Journal:  Iran J Microbiol       Date:  2021-04

10.  Isolation, Characterization and Genomic Analysis of a Novel Bacteriophage VB_EcoS-Golestan Infecting Multidrug-Resistant Escherichia coli Isolated from Urinary Tract Infection.

Authors:  Mahsa Yazdi; Majid Bouzari; Ezzat Allah Ghaemi; Khashayar Shahin
Journal:  Sci Rep       Date:  2020-05-06       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.